Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Annals of Medicine and Surgery (2012)|October 10, 2022
Development of facial palsy following COVID-19 vaccination: A systematic reviewMaman Khurshid, Iflah Ansari, Hafsa Ahmad, et al.Infection and Drug Resistance|March 2, 2023
Singapore's Dengue Outbreak Amidst the COVID-19 Pandemic: Challenges, Responses, and LessonsHuzaifa Ahmad Cheema, Rustam Shariq Mujtaba, Amna Siddiqui, et al.Pediatric Quality & Safety|October 4, 2019
Quality Initiative to Reduce Cardiac CT Angiography Radiation Exposure in Patients with Congenital Heart DiseaseFatima Ali, Arjumand Rizvi, Huzaifa Ahmad, et al.Food Science & Nutrition|March 8, 2024
<i>Nigella sativa</i> for the treatment of COVID-19 patients: A rapid systematic review and meta-analysis of randomized controlled trialsMohammad Umer, Aiman Naveed, Qanita Maryam, et al.American Heart Journal Plus : Cardiology Research and Practice|March 26, 2026
Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in US adults, 1999-2018Huzaifa Ahmad Cheema, Abia Shahid, Saad Ur Rahman, et al.Journal of Medical Virology|May 15, 2023
Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trialsHuzaifa Ahmad Cheema, Aqeeb Ur Rehman, Asmaa Ahmed Elrashedy, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 31, 2024
Gene polymorphisms and risk of idiopathic pulmonary fibrosis: a systematic review and meta-analysisMaryam Hassan, Akbar Shoukat Ali, Ali Bin Sarwar Zubairi, et al.Nutrients|April 23, 2022
Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled TrialsHuzaifa Ahmad Cheema, Abia Shahid, Muhammad Ayyan, et al.Dermatologic Therapy|October 24, 2022
Benvitimod for the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trialsMuhammad Ehsan, Aqeeb Ur Rehman, Farwa Athar, et al.Medicine|December 20, 2023
Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysisUmmi Aiman Rahman, Talha Bin Kashif, Muhammad Usman, et al.Pageof 10